CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005465
NCT00005465N/ACompleted
CompareCT.gov

Genetic Mapping of Atherogenic Lipoprotein Phenotypes

University of Washington·observational·Posted May 26, 2000·Updated Feb 10, 2016

In Brief

An observational study for Atherosclerosis and 2 related conditions. Completed.

Detailed Summary

To map the major gene influencing low-density lipoprotein subclass phenotypes, denoted atherogenic lipoprotein (ALP) phenotypes, with a long term goal of cloning the ALP gene and understanding its role in genetic susceptibility to atherosclerosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Cardiovascular Diseases, Heart Diseases
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartAug 1, 1991
Study CompletionJul 1, 1996
TodayJul 2, 2026
Posted 26.1 years ago